2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014
Nov 08, 2017G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights
Nov 08, 2017G1 Therapeutics Makes Key Executive Appointments
Nov 07, 2017G1 Therapeutics to Present at Stifel 2017 Healthcare Conference
Nov 06, 2017G1 Therapeutics Announces Publication in Cancer Discovery Demonstrating That CDK4/6 Inhibition Enhances the Anti-Tumor T Cell Response
Sep 18, 2017G1 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
Aug 09, 2017G1 Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights
Aug 08, 2017G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference
Aug 03, 2017G1 Therapeutics Makes Key Appointments to Management Team
Jul 27, 2017G1 Therapeutics to Ring Nasdaq Stock Market Closing Bell on Wednesday, August 2, 2017
Jul 13, 2017G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors
May 30, 2017G1 Therapeutics to Present Clinical Data on CDK4/6 Inhibitor Trilaciclib at the 2017 American Society of Clinical Oncology Annual Meeting
May 23, 2017G1 Therapeutics Announces Closing of Initial Public Offering
May 16, 2017G1 Therapeutics Announces Pricing of Initial Public Offering
May 08, 2017G1 Therapeutics Announces Launch of Initial Public Offering
Mar 29, 2017G1 Therapeutics Announces Presentations at the 2017 American Association for Cancer Research Annual Meeting
Jan 10, 2017G1 Therapeutics Initiates Three Drug Development Programs in Breast Cancer
Jan 03, 2017G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference